In episode 7 of The MedSpresso Podcast, we examine the past month’s biggest Alzheimer’s news.
Story 1: Using biomarkers to diagnose very early-onset Alzheimer’s disease.
Story 2: Identifying Alzheimer’s patients at the greatest risk of anti-amyloid side effects.
Story 3: The AI-guided tool that can predict which cases of mild cognitive impairment will progress to Alzheimer’s disease.
Get the full score of each week’s healthcare news with our weekly MedSpresso newsletter. The healthcare landscape changes daily; don’t get left behind. Join for free at medspresso.io
Share this post